AWHP CEO Millicent Gorham comments on CMS’ decision not to finalize a proposed rule that would have required coverage of GLP-1s under Medicare Part D and Medicaid.

AWHP CEO Millicent Gorham comments on CMS’ decision not to finalize a rule that would have included coverage for obesity medications through Medicare Part D and Medicaid.

AWHP CEO Millicent Gorham comments on how coverage for obesity medications can boost workplace productivity.

AWHP and other organizations urged employers to cover the “full range of evidence-based obesity care options,” including medical nutrition therapy, intensive behavioral therapy, surgery and medications.

AWHP’s letter led a letter pushing employers to cover obesity the same way they would for any other chronic disease.

AWHP CEO Millicent Gorham discusses coverage of obesity medications through employers.

AWHP led an effort to encourage employers to cover all evidence-based obesity care options.

The EveryBODY Covered campaign’s open letter to employers encouraged them to offer coverage for obesity as they would for other chronic conditions.

AWHP’s poll in collaboration with Ipsos found that 42% of women are forgoing critical preventive health services.